![Leverne Marsh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leverne Marsh
Corporate Officer/Principal bei
PHARMING GROUP N.V.
Profil
Leverne Marsh is currently Chief Commercial Officer at Pharming Group NV since 2026.
Former positions include Executive Vice President-Marketing at DexCom, Inc. and Chief Product Officer & SVP-Pharma Strategy at Novartis AG.
Education includes an undergraduate degree from Nelson Mandela Metropolitan University.
Aktive Positionen von Leverne Marsh
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMING GROUP N.V. | Corporate Officer/Principal | 01.01.2026 |
Ehemalige bekannte Positionen von Leverne Marsh
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
| DEXCOM, INC. | Vertrieb & Marketing | - |
Ausbildung von Leverne Marsh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Nelson Mandela Metropolitan University
 Nelson Mandela Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
